BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28290080)

  • 1. A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics.
    Jiang Y; McCombs JS; Park SH
    CNS Drugs; 2017 Apr; 31(4):319-326. PubMed ID: 28290080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study.
    Hwang YJ; Dixon SN; Reiss JP; Wald R; Parikh CR; Gandhi S; Shariff SZ; Pannu N; Nash DM; Rehman F; Garg AX
    Ann Intern Med; 2014 Aug; 161(4):242-8. PubMed ID: 25133360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Antipsychotics and the Risks of Acute Kidney Injury and Related Outcomes Among Older Adults: A Replication Analysis and an Evaluation of Adapted Confounding Control Strategies.
    Ryan PB; Schuemie MJ; Ramcharran D; Stang PE
    Drugs Aging; 2017 Mar; 34(3):211-219. PubMed ID: 28124262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization.
    Jiang Y; Ni W
    Pharmacotherapy; 2015 Sep; 35(9):813-22. PubMed ID: 26406773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.
    Citrome L; Kalsekar I; Guo Z; Laubmeier K; Hebden T
    Clin Ther; 2013 Dec; 35(12):1867-75. PubMed ID: 24119767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    Kim E; You M; Pikalov A; Van-Tran Q; Jing Y
    BMC Psychiatry; 2011 Jan; 11():6. PubMed ID: 21214937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical care costs and hospitalization in patients with bipolar disorder treated with atypical antipsychotics.
    Bergeson JG; Kalsekar I; Jing Y; You M; Forbes RA; Hebden T
    Am Health Drug Benefits; 2012 Sep; 5(6):379-86. PubMed ID: 24991334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications.
    Gianfrancesco F; Rajagopalan K; Goldberg JF; Wang RH
    Bipolar Disord; 2007 May; 9(3):252-61. PubMed ID: 17430300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative risk of seizure with use of first- and second-generation antipsychotics in patients with schizophrenia and mood disorders.
    Wu CS; Wang SC; Yeh IJ; Liu SK
    J Clin Psychiatry; 2016 May; 77(5):e573-9. PubMed ID: 27249081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    Pharmacotherapy; 2007 Jan; 27(1):27-35. PubMed ID: 17192159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of ischemic stroke associated with the use of antipsychotic drugs in elderly patients: a retrospective cohort study in Korea.
    Shin JY; Choi NK; Lee J; Seong JM; Park MJ; Lee SH; Park BJ
    PLoS One; 2015; 10(3):e0119931. PubMed ID: 25790285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics.
    Ng-Mak D; Halpern R; Rajagopalan K; Loebel A
    Curr Med Res Opin; 2019 Feb; 35(2):211-219. PubMed ID: 29625538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
    Jing Y; Johnston SS; Fowler R; Bates JA; Forbes RA; Hebden T
    J Med Econ; 2011; 14(6):777-86. PubMed ID: 21954966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics.
    Yan T; Greene M; Chang E; Hartry A; Touya M; Broder MS
    Curr Med Res Opin; 2018 Jan; 34(1):41-47. PubMed ID: 29057674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.